VIVA IN VITRO
Contact information
- A. Health Biotechnology
- Areas of activity
- Biomarkers
- In vitro diagnostics
- Medical devices
- Therapeutic areas
- Inflammatory diseases
- Immunology
- Blood and lymphatic system
Sepsis is the first cause of in-hospital mortality. Our mission is saving lives by reducing sepsis mortality, and by contributing to the development of novel therapies for inflammatory conditions and autoimmune diseases.
IVD technique for septic patient’s stratification, that detects whether the patient is immunosuppressed or not., based on NLRP3; clinically proven.
Currently developing a compact automated device for septic patient stratification, for use in the hospital lab.
Development of novel therapies in different indications requiring patient’s stratification in the clinical trials recruitment process, dependant on the capacity to activate NLRP3 inflammasome or not.
Joint developments of either Devices or disposable Lab Chips intended for different sepsis conditions and other indications.